Biocon hit with FDA 483 after inspection of API facility
US FDA issues Form 483 to Biocon facility after preapproval and GMP inspections.
Archives for February 6, 2020
Novartis, Gilead in joint financing of personalized medicine platform
Vineti’s latest financing round sees Novartis and Gilead join forces to invest in technology platform that enables scale-up of CAR Ts and allogeneic cell therapies.
CRO ‘adding expertise’ to respond to the evolution of biometrics
Acquisition of Clindata’s human health biometrics division is expected to increase Synteract’s geographical footprint along with the adaptability of its biometrics services solutions.